|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 543.35 USD | +1.06% |
|
-1.25% | -6.70% |
| 07-22 | BofA Securities Adjusts Price Target on Madrigal Pharmaceuticals to $553 From $542 | MT |
| 07-21 | Madrigal Pharmaceuticals Insider Sold Shares Worth $1,368,253, According to a Recent SEC Filing | MT |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bullish | Bullish | Neutral |
| Resistance | 565.4 | 565.4 | 598.91 |
| Spread/Res. | -3.90% | -3.90% | -9.28% |
| Spread/Supp. | +5.63% | +9.32% | +29.71% |
| Support | 514.39 | 497.03 | 418.9 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- MDGL Stock
- Charts Madrigal Pharmaceuticals, Inc.
Select your edition
All financial news and data tailored to specific country editions
